Shopping Cart
- Remove All
Your shopping cart is currently empty
Immuno modulator-1 (compound 22) effectively suppresses the secretion of TNFα and IL-2 in human peripheral blood mononuclear cells (hPBMC), with IC50 values of 4.7 nM and 26 nM, respectively, and exhibits a 20% inhibitory effect on the hERG potassium channel at a concentration of 3 μM [1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks |
| Description | Immuno modulator-1 (compound 22) effectively suppresses the secretion of TNFα and IL-2 in human peripheral blood mononuclear cells (hPBMC), with IC50 values of 4.7 nM and 26 nM, respectively, and exhibits a 20% inhibitory effect on the hERG potassium channel at a concentration of 3 μM [1]. |
| In vitro | Immune modulator-1 (compound 22) inhibits the proliferation of NCI-H929 human myeloma cells with an IC50 of 0.6 nM [1]. |
| In vivo | Immuno modulator-1 (compound 22) administered at 1 mg/kg IV and 5 mg/kg PO demonstrated 30% oral bioavailability in male Sprague-Dawley rats [1]. |
| Molecular Weight | 582.62 |
| Formula | C32H31FN6O4 |
| Cas No. | 2757469-20-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.